Key Telehealth Factors to Monitor

Article

When providing telehealth, providers must check individual state laws and policies regarding telehealth and providing telehealth across state lines. In sum, there is a lot to stay on top of in relation to telehealth.

Ateev Mehrotra, MD

Ateev Mehrotra, MD

The largest effect on telemedicine in patients who live near a state border, those in rural locales, and those who received primary care or mental health treatment, may be out-of-state licensure restrictions, according to investigational of a cross=sectional study published in JAMA Health Forum.1

“The first half of 2021, more than 422,500 patients with Medicare had an out-of-state telehealth visit.” Of those visits, the top three types of care that were sought across state lines were primary care, mental health, and cancer, wrote investigators led by Ateev Mehrotra, MD of Harvard Medical School.

Like in person visits, documentation in the medical record to substantiate a code that is submitted for reimbursement is required. An additional item to include when doing a telehealth visit is the type of communication utilized – audio only or audio/video. This makes a difference in terms of the code(s) submitted, as well as the reimbursement. On August 10, 2022, the U.S. Department of Health and Human Services (“HHS”) announced its telehealth policy changes when the COVID-19 public health emergency ends. Currently, the COVID-19 public health emergency is effective through October 13, 2022. If the public emergency is not extended, there is 151-day extension period in place to provide a transition period. Here are some key considerations:

  • Medicare patients can now receive telehealth services, including audio-only services for mental/behavioral healthcare in their homes in any part of the country if certain conditions are met.
  • Increased flexibility regarding where the patient receives Medicare telehealth services, as well as where the services originate will revert back to match the restrictions that were in place prior to the COVID-19 public health emergency.
  • Medicare reimbursement for mental health telehealth services will again require an in-person visit within 6 months of initial assessment and every 12 months following.
  • Medicare reimbursement for telehealth visits furnished by physical therapists, occupational therapists, speech language pathologists, and audiologists will no longer be allowed.
  • Medicare will no longer cover audio-only visits for physical health encounters.
  • FQHCs and RHCs will no longer be able to be reimbursed as distant site telehealth providers for non-mental health services.

Another area that cannot be overlooked is HIPAA compliance for providers and cybersecurity protections for both providers and patients. On September 29, 2022, the Government Accounting Office (“GAO”) issued a report, Medicare Telehealth – Actions Needed to Strengthen Oversight and Help Providers Educate Patients on Privacy and Security Risks. The top four recommendations, which affect CMS, HHS Office for Civil Rights, providers, and patients include the following:

  1. CMS – providers should be required to use available site of service codes to indicate when Medicare telehealth services are delivered to beneficiaries in their homes.
  2. CMS – should assess the quality of Medicare services, including audio-only services, delivered using telehealth.
  3. HHS-OCR – should provide additional education, outreach, or other assistance to providers to help them explain the privacy and security risks to patients in plain language when using video telehealth platforms to provide telehealth services.

Finally, providers need to check individual state laws and policies regarding telehealth and providing telehealth across state lines. In sum, there is a lot to stay on top of in relation to telehealth.

REFERENCES:

Mehrotra A, Huskamp HA, Nimgaonkar A, et al. Receipt of out-of-state telemedicine visits among medicare beneficiaries during the COVID-19 pandemic. JAMA Health Forum. 2022;3(9):e223013. doi:10.1001/jamahealthforum.2022.3013

Related Videos
Andrew Kuykendall, MD, an expert on polycythemia vera
Andrew Kuykendall, MD, an expert on polycythemia vera
Andrew Kuykendall, MD, an expert on polycythemia vera
Andrew Kuykendall, MD, an expert on polycythemia vera
Andrew Kuykendall, MD, an expert on polycythemia vera
Andrew Kuykendall, MD, an expert on polycythemia vera
Andrew Kuykendall, MD, an expert on polycythemia vera
Andrew Kuykendall, MD, an expert on polycythemia vera
Prithviraj Bose, MD, an expert on myelofibrosis
Prithviraj Bose, MD, an expert on myelofibrosis
Related Content